# Sacituzumab Tirumotecan in Previously Treated TROP2-Positive Advanced Biliary Tract Cancer

Source: https://onco.cc/trials/nct07701122/  
OnCo record `nct07701122` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of sacituzumab tirumotecan in gallbladder cancer and other biliary tract cancers, run by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, not yet recruiting.

## Summary

Sacituzumab Tirumotecan in Previously Treated TROP2-Positive Advanced Biliary Tract Cancer is a phase 2 interventional study registered as NCT07701122 by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, with a registry enrolment figure of 33 participants, started 2026-07-01 and due to reach its primary completion in 2027-07-01. Interventions recorded: Sacituzumab Tirumotecan (SKB264). Conditions listed: Advanced Biliary Tract Cancer(BTC). No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-09-24
- Tags: ctgov-ingest; gallbladder-deep-dive
- Registry id: NCT07701122
- Phase: 2
- Setting: A Single-Arm, Phase II, Multicenter Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan as Second-Line or Later Therapy in Patients With TROP2-Positive Advanced Biliary Tract Cancer
- Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Enrolled: 33

## Sources

- ClinicalTrials.gov NCT07701122: https://clinicaltrials.gov/study/NCT07701122

## Connected records

- cancers: [Biliary tract cancer (all types)](https://onco.cc/cancers/biliary-tract-cancer/), [Biliary tract cancer (cholangiocarcinoma)](https://onco.cc/cancers/cholangiocarcinoma/), [Gallbladder cancer](https://onco.cc/cancers/gallbladder/)
- technologies: [Antibody-drug conjugate (ADC)](https://onco.cc/technologies/adc/)
- drugs: [Sacituzumab tirumotecan](https://onco.cc/drugs/sacituzumab-tirumotecan/)
- terms: [Gallbladder cancer in biliary tract cancer trials (eligibility and subgroups)](https://onco.cc/terms/gallbladder-cancer-in-biliary-trials/)

---
JSON: https://onco.cc/api/v1/entities/nct07701122.json